Concentrix: Q4 Earnings Insights

Concentrix (NASDAQ:CNXC) reported its Q4 earnings results on Wednesday, January 24, 2024 at 04:10 PM. Here’s what investors…

Concentrix (NASDAQ:CNXC) reported its Q4 earnings results on Wednesday, January 24, 2024 at 04:10 PM.

Here’s what investors need to know about the announcement.

Earnings

Concentrix beat estimated earnings by 9.09%, reporting an EPS of $3.36 versus an estimate of $3.08.

Revenue was up $590.00 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.13 which was followed by a 6.84% increase in the share price the next day.

Here’s a look at Concentrix’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 2.84 2.52 2.59 3.33
EPS Actual 2.71 2.69 2.56 3.01
Revenue Estimate 1.64B 1.52B 1.63B 1.68B
Revenue Actual 1.63B 1.61B 1.64B 1.64B

To track all earnings releases for Concentrix visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

California Cannabis Co. Blüm Reports 36% YoY Drop In 2023 Revenue, Narrows Net Loss By 93%

California cannabis producer Blüm Holdings Inc. announced on Tuesday financial results for the full year and fourth quarter ended Dec. 31, 2023. The company reported a 36% year-over-year drop in revenue to $33.2 million, due to a "strategic slowdown in its underperforming distribution segment." However, the company's CFO Patty Chan said the decrease in gross margin was only $0.5 million on a revenue decrease of $18.8 million. "2023 was a truly transformative year for Blüm Holdings during which the Company focused on disposing nearly all the company's underperforming assets and significantly reducing selling, general, and administrative expenses while simultaneously realigning our strategic focus to increasing our gross margin from 35% in 2022 to 53% in 2023," Chan said.

BLMH